Liver grafts preserved in celsior solution as source of hepatocytes for drug metabolism studies: Comparison with surgical liver biopsies

被引:13
作者
Donato, MT
Serralta, A
Jiménez, N
Pérez, G
Castell, JV
Gómez-Lechón, MJ
机构
[1] Hosp Univ La Fe, Unidad Hepatol Expt, Ctr Invest, Valencia 46009, Spain
[2] Hosp Univ La Fe, Unidad Cirugia & Transplante Hepat, Valencia 46009, Spain
关键词
D O I
10.1124/dmd.104.001545
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Suitability of human liver grafts preserved in Celsior solution (CS) for preparing metabolically competent hepatocyte cultures has been examined. To this end, basal and induced activity and mRNA levels of major hepatic cytochrome P450 (P450) enzymes have been measured. By 24 h in culture, measurable levels of the 10 P450 mRNAs studied were found in all hepatocyte preparations examined, with CYP2E1, CYP2C9, and CYP3A4 mRNAs being the most abundant. Compared with hepatocytes obtained from surgical liver resections (SLRs), lower content of each P450 mRNA was found in hepatocytes from the CS group; however, the relative distribution of individual P450 mRNAs was similar. Similar results were observed after measuring P450 activities. CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2E1, and CYP3A4 activities in hepatocytes from CS-flushed grafts were lower than but comparable with those of cultures prepared from SLRs. No differences in the metabolite profile of testosterone were found. Treatment of hepatocytes from CS-preserved grafts with model P450 inducers shows that 2 muM methylcholanthrene only increased CYP1A1 and CYP1A2 mRNAs (>100-fold over control), 1 mM phenobarbital markedly increased CYP2A6, CYP2B6, and CYP3A4 mRNA content (>7-fold), and 50 muM rifampicin highly increased CYP3A4 mRNA levels (>10-fold), whereas minor effects (<3-fold) were observed in CYP2A6, CYP2B6, and CYP2C9 mRNAs. This induction pattern of P450s was similar, in terms of magnitude, reproducibility, and specificity, to that shown in primary hepatocytes from surgical biopsies. Overall, our results indicate that, cold-preserved in CS, liver grafts constitute a valuable source of human hepatocytes for drug metabolism studies.
引用
收藏
页码:108 / 114
页数:7
相关论文
共 37 条
[1]   Induction of necrosis and DNA fragmentation during hypothermic preservation of hepatocytes in UW, HTK, and Celsior solutions [J].
Abrahamse, SL ;
Heimel, PV ;
Hartman, RJ ;
Chamuleau, RAFM ;
van Gulik, TM .
CELL TRANSPLANTATION, 2003, 12 (01) :59-68
[2]   Differential alteration of cytochrome P450 isoenzymes in two experimental models of cirrhosis [J].
Bastien, MC ;
Leblond, F ;
Pichette, V ;
Villeneuve, JP .
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2000, 78 (11) :912-919
[3]   High expression of human CYP2C in immortalized human liver epithelial cells [J].
Bort, R ;
Castell, JV ;
Pfeifer, A ;
Gómez-Lechón, MJ ;
Macé, K .
TOXICOLOGY IN VITRO, 1999, 13 (4-5) :633-638
[4]   HUMAN HEPATOCYTES ARE MORE RESISTANT THAN RAT HEPATOCYTES TO ANOXIA-REOXYGENATION INJURY [J].
CARACENI, P ;
GASBARRINI, A ;
NUSSLER, A ;
DISILVIO, M ;
BARTOLI, F ;
BORLE, AB ;
VANTHIEL, DH .
HEPATOLOGY, 1994, 20 (05) :1247-1254
[5]   A Multicenter pilot prospective study comparing Celsior and University of Wisconsin preserving solutions for use in liver transplantation [J].
Cavallari, A ;
Cillo, U ;
Nardo, B ;
Filipponi, F ;
Gringeri, E ;
Montalti, R ;
Vistoli, F ;
D'Amico, F ;
Faenza, A ;
Mosca, F ;
Vitale, A ;
D'Amico, D .
LIVER TRANSPLANTATION, 2003, 9 (08) :814-821
[6]   Metabolic capacities in cultured human hepatocytes obtained by a new isolating procedure from non-wedge small liver biopsies [J].
David, P ;
Viollon, C ;
Alexandre, E ;
Azimzadeh, A ;
Nicod, L ;
Wolf, P ;
Jaeck, D ;
Boudjema, K ;
Richert, L .
HUMAN & EXPERIMENTAL TOXICOLOGY, 1998, 17 (10) :544-553
[7]  
Donato MT, 1998, ATLA-ALTERN LAB ANIM, V26, P213
[8]   A MICROASSAY FOR MEASURING CYTOCHROME-P450IA1 AND CYTOCHROME-P450IIB1 ACTIVITIES IN INTACT HUMAN AND RAT HEPATOCYTES CULTURED ON 96-WELL PLATES [J].
DONATO, MT ;
GOMEZLECHON, MJ ;
CASTELL, JV .
ANALYTICAL BIOCHEMISTRY, 1993, 213 (01) :29-33
[9]  
DONATO MT, 1995, DRUG METAB DISPOS, V23, P553
[10]   Characterization of drug metabolizing activities in pig hepatocytes for use in bioartificial liver devices:: comparison with other hepatic cellular models [J].
Donato, MT ;
Castell, JV ;
Gómez-Lechón, MJ .
JOURNAL OF HEPATOLOGY, 1999, 31 (03) :542-549